20.35
price up icon4.41%   0.86
pre-market  시장 영업 전:  21.40   1.05   +5.16%
loading
전일 마감가:
$19.49
열려 있는:
$19.57
하루 거래량:
889.50K
Relative Volume:
0.64
시가총액:
$178.39M
수익:
-
순이익/손실:
$-121.02M
주가수익비율:
-1.8073
EPS:
-11.26
순현금흐름:
$-114.09M
1주 성능:
+2.57%
1개월 성능:
-15.94%
6개월 성능:
+14.20%
1년 성능:
+22.96%
1일 변동 폭
Value
$19.57
$20.58
1주일 범위
Value
$18.53
$20.58
52주 변동 폭
Value
$7.31
$130.00

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Company Profile

Name
명칭
Tonix Pharmaceuticals Holding Corp
Name
전화
212-980-9155
Name
주소
26 MAIN STREET, SUITE 101, CHATHAM, NY
Name
직원
81
Name
트위터
@TONIXPharma
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
TNXP's Discussions on Twitter

TNXP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TNXP
Tonix Pharmaceuticals Holding Corp
20.35 170.85M 0 -121.02M -114.09M -11.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.17 108.04B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.58 60.75B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.31 61.26B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
829.83 50.32B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
164.02 33.75B 398.11M -1.03B -868.57M -5.7032

토닉스 파마슈티컬스 홀딩 Stock (TNXP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-04-18 개시 Noble Capital Markets Outperform
2019-04-18 업그레이드 ROTH Capital Neutral → Buy
2017-08-18 업그레이드 ROTH Capital Neutral → Buy
2016-09-07 다운그레이드 ROTH Capital Buy → Neutral
2016-02-17 재확인 Oppenheimer Outperform
2015-11-04 개시 Cantor Fitzgerald Buy
2015-06-12 개시 Oppenheimer Outperform
2015-02-17 재확인 ROTH Capital Buy
2014-09-29 재확인 ROTH Capital Buy
모두보기

토닉스 파마슈티컬스 홀딩 주식(TNXP)의 최신 뉴스

pulisher
02:01 AM

How to build a dashboard for Tonix Pharmaceuticals Holding Corp. stockOil Prices & Capital Protection Trade Alerts - newser.com

02:01 AM
pulisher
12:37 PM

Is Tonix Pharmaceuticals Holding Corp. stock trading at a premium valuationMarket Sentiment Summary & Precise Swing Trade Alerts - newser.com

12:37 PM
pulisher
Oct 27, 2025

Sentiment analysis tools applied to Tonix Pharmaceuticals Holding Corp.M&A Rumor & Safe Entry Trade Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals Holding Corp. stock trend forecastTrade Entry Report & Reliable Price Breakout Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

How to recover losses in Tonix Pharmaceuticals Holding Corp. stockTrade Exit Report & Low Drawdown Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix’s fibromyalgia drug shows significant pain reduction in study By Investing.com - Investing.com Nigeria

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals (TNXP) Unveils Positive Trial Results for Tonmya - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix PharmaceuticalsPrelim Q3 net revenue from product sales $3.3 millionSEC filing - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

Tonix (Nasdaq: TNXP) reports Phase 3 Tonmya fibromyalgia data: Week 14 pain reduction - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Is Tonix Pharmaceuticals Holding Corp. stock a safe haven assetEarnings Overview Summary & Low Risk High Reward Ideas - newser.com

Oct 27, 2025
pulisher
Oct 24, 2025

First patient dosed in MGH-Led FOCUS study of Tonix’s investigational intranasal Oxytocin product - Proactive financial news

Oct 24, 2025
pulisher
Oct 24, 2025

Understanding Momentum Shifts in (TNXP) - news.stocktradersdaily.com

Oct 24, 2025
pulisher
Oct 23, 2025

Tonix: Assessing Tonmya's Commercial Potential Ahead Of Q4 2025 Launch - Seeking Alpha

Oct 23, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals (TNXP) Launches New Study for Rare Endocri - GuruFocus

Oct 22, 2025
pulisher
Oct 22, 2025

Can Tonix Pharmaceuticals Holding Corp. recover in the next quarterPortfolio Risk Report & Real-Time Volume Spike Alerts - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix (Nasdaq: TNXP) doses first patient in MGH FOCUS AVP-D study testing 6 IU and 24 IU - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

Tonix Pharmaceuticals Holding Corp. stock daily chart insightsTrade Risk Report & Daily Price Action Insights - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence - The Manila Times

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharmaceuticals Announces Poster Presentation of Tonmya™ at 2025 American College of Rheumatology Convergence - Quiver Quantitative

Oct 21, 2025
pulisher
Oct 21, 2025

Tonix Pharma (Nasdaq: TNXP) to present Tonmya fibromyalgia data at ACR 2025 on Oct 27 - Stock Titan

Oct 21, 2025
pulisher
Oct 21, 2025

What analysts say about Tonix Pharmaceuticals Holding Corp stockSmall Cap Stock Opportunities & Small Investment Trading Growth - earlytimes.in

Oct 21, 2025

토닉스 파마슈티컬스 홀딩 (TNXP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.26
price up icon 0.00%
$93.08
price up icon 1.97%
$29.03
price down icon 2.88%
$106.05
price up icon 0.37%
biotechnology ONC
$315.43
price up icon 1.49%
$164.02
price up icon 2.73%
자본화:     |  볼륨(24시간):